Physician profile
Gary Ray Walker
NPI 1902315146
$543.65
in general payments reported to CMS, 2019-2025
13 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.05 · 2022: $159 · 2023: $108 · 2024: $76.60 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $127.68 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $99.99 | 2022 | |
| Tolmar, INC. | $51.11 | 2025 | Jatenzo, Eligard |
| Myovant Sciences INC. | $45.93 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $42.08 | 2022-2023 | Pylarify |
| Urogen Pharma, INC. | $34.53 | 2025 | |
| Coloplast Corp | $33.55 | 2025 | |
| Abbvie INC. | $21.87 | 2023 | |
| Teleflex LLC | $19.74 | 2024 | |
| Endo Pharmaceuticals INC. | $18.94 | 2024 | Aveed, Xiaflex |
| Endo USA, INC. | $17.86 | 2025 | Xiaflex, Aveed |
| Photocure INC | $16.29 | 2024 | Cysview |
| Olympus America INC. | $14.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.